Search - tctmd.com

Displaying 861 - 880 of 1159

Sort: Relevancy | Date

News Daily News

High-Dose Edoxaban as Effective as Warfarin for Stroke Prevention in A-fib

Yael L. Maxwell

June 27, 2014

Presentation

Cerebrovascular Events in 21,105 Patients with A-fib Randomized to Edoxaban Versus Warfarin

Presenter: Robert P. Giugliano

June 24, 2014

Presentation TVT 2014

A Critical Analysis of Present Data on Cerebral Protection after TAVR

Presenter: Axel Linke

June 07, 2014

Presentation TVT 2014

Why Cerebral Protection after TAVR Will Become the Standard of Care

Presenter: Eberhard Grube

June 07, 2014

Presentation TVT 2014

Why Cerebral Protection after TAVR Will be Used Sparingly (if at all) in the Future

Presenter: Ganesh Manoharan

June 07, 2014

Presentation TVT 2014

A Rationale Approach to Adjunct Pharmacotherapy After TAVR (With Stroke in Mind)

Presenter: Susheel Kodali

June 07, 2014

Presentation TVT 2014

Has Stroke Frequency Declined After TAVR?

Presenter: Nicolas M. van Mieghem

June 07, 2014

Presentation TVT 2014

Perspectives from the US CoreValve Trials

Presenter: Jeffrey J. Popma

June 07, 2014

Presentation TVT 2014

Perspectives from the PARTNER Trials

Presenter: Susheel Kodali

June 07, 2014

Presentation TVT 2014

Incidence, Timing, Predictors (New Onset AF, Postdilatation, etc.), and Clinical Impact

Presenter: Samir R. Kapadia

June 07, 2014

Presentation TVT 2014

Stroke Basics after Cardiovascular Interventions: VARC 2 Definitions, Stroke Severity Assessment, Neuroimaging, and Neurocognitive Function

Presenter: Martin B. Leon

June 07, 2014

News Conference News EuroPCR 2014

New Iteration of Sapien Device Associated with Low Rates of Early Mortality, Stroke

L.A. McKeown

May 23, 2014

Presentation

Evaluation of Interval Times from Onset to Reperfusion in Pts Undergoing Endovascular Therapy

Presenter: Mayank Goyal

May 13, 2014

News Daily News

IMS III Substudy Identifies Reasons for Endovascular Treatment Delays in Acute Stroke Patients

Yael L. Maxwell

May 13, 2014

Presentation

Stroke After Aortic Valve Surgery

Presenter: Steven R. Mess?

May 08, 2014

News Daily News

Clinical Stroke Rate After Open AVR Higher than Expected

Leah Lawrence

May 08, 2014

Presentation

Rivaroxaban for Stroke Prevention in East Asian Patients from the ROCKET AF Trial

Presenter: Ka Sing Lawrence Wong

April 29, 2014

News Daily News

ROCKET AF Substudy: Rivaroxaban Safe, Effective in East Asian Patients

L.A. McKeown

April 29, 2014

Presentation

Door-to-Needle (DTN) Times for tPA and Clinical Outcomes in Acute Ischemic Stroke Before and After a Quality Improvement Initiative

Presenter: Gregg C. Fonarow

April 23, 2014

News Daily News

Society-Led Quality Improvement Effort Speeds Treatment for Acute Ischemic Stroke

Caitlin E. Cox

April 23, 2014

Advertisement

High-Dose Edoxaban as Effective as Warfarin for Stroke Prevention in A-fib

Cerebrovascular Events in 21,105 Patients with A-fib Randomized to Edoxaban Versus Warfarin

A Critical Analysis of Present Data on Cerebral Protection after TAVR

Why Cerebral Protection after TAVR Will Become the Standard of Care

Why Cerebral Protection after TAVR Will be Used Sparingly (if at all) in the Future

A Rationale Approach to Adjunct Pharmacotherapy After TAVR (With Stroke in Mind)

Has Stroke Frequency Declined After TAVR?

Perspectives from the US CoreValve Trials

Perspectives from the PARTNER Trials

Incidence, Timing, Predictors (New Onset AF, Postdilatation, etc.), and Clinical Impact

Stroke Basics after Cardiovascular Interventions: VARC 2 Definitions, Stroke Severity Assessment, Neuroimaging, and Neurocognitive Function

New Iteration of Sapien Device Associated with Low Rates of Early Mortality, Stroke

Evaluation of Interval Times from Onset to Reperfusion in Pts Undergoing Endovascular Therapy

IMS III Substudy Identifies Reasons for Endovascular Treatment Delays in Acute Stroke Patients

Stroke After Aortic Valve Surgery

Clinical Stroke Rate After Open AVR Higher than Expected

Rivaroxaban for Stroke Prevention in East Asian Patients from the ROCKET AF Trial

ROCKET AF Substudy: Rivaroxaban Safe, Effective in East Asian Patients

Door-to-Needle (DTN) Times for tPA and Clinical Outcomes in Acute Ischemic Stroke Before and After a Quality Improvement Initiative

Society-Led Quality Improvement Effort Speeds Treatment for Acute Ischemic Stroke

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content